605
Participants
Start Date
November 1, 2020
Primary Completion Date
January 30, 2021
Study Completion Date
June 30, 2021
Initial Medication Adherence (IMA) Intervention
The IMA intervention promotes health literacy and patient participation in the decision-making process during the recommendation and prescription of a new drug for the management of cardiovascular disease and diabetes. The IMA intervention has four main components: 1. Training for healthcare professionals (GPs, nurses, and community pharmacists) on non-initiation, shared-decision making, health literacy and use of decision aids; 2. Intervention support tools; decision aids (leaflets and website) and implementation tools (dispensing alert in community pharmacies when dispensing insulins and antiplatelet drugs); 3. Shared decision-making process during the GP's consultation; and 4. Information support provided by the nurses and community pharmacists that use the intervention decision aids to explore the patients' doubts and standardise the discourse between primary healthcare professionals.
Usual Care
Patients received the usual care when being prescribed a new prescription for treatments of cardiovascular disease or diabetes. Nurses and community pharmacists were asked to also provide usual care to those patients. Community pharmacists from the control group had the dispensing alert available when dispensing insulins and antiplatelet drugs.
CAP Cornellà de Llobregat (La Gavarra), Cornellà de Llobregat
Centro de Asistencia Primaria (CAP) Dr. Pujol i Capsada (CAP Pujol i Capsada), el Prat de Llobregat
CAP Dr. Bartomeu Fabrés Anglada Gava 2, Gavà
CAP Florida Nord (CAP la Florida), L'Hospitalet de Llobregat
CAP Florida Sud (CAP la Florida), L'Hospitalet de Llobregat
Parc Sanitari Sant Joan de Déu
OTHER
Institut Català de la Salut
OTHER
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
OTHER
Col·legi de Farmacèutics de la Província de Barcelona
OTHER
CIBER of Epidemiology and Public Health
UNKNOWN
Fundació Sant Joan de Déu
OTHER